theofol comp oraaliliuos
takeda oy takeda oy - guaifenesinum,theophyllinum monohydricum - oraaliliuos - teofylliini, yhdistelmävalmisteet
feraccru
norgine b.v. - ferri maltolia - anemia, raudanvajaus - antianemiset valmisteet - feraccru on tarkoitettu aikuisten hoitoon raudanpuute.
cetraxal comp 3 mg/ml + 0,25 mg/ml korvatipat, liuos
poa pharma scandinavia ab - fluocinolone acetonide, ciprofloxacin hydrochloride - korvatipat, liuos - 3 mg/ml + 0,25 mg/ml - fluosinoloniasetonidi ja mikrobilääkkeet
cetraxal comp 3 mg/ml + 0,25 mg/ml korvatipat, liuos, kerta-annospakkaus
poa pharma scandinavia ab - fluocinolone acetonide, ciprofloxacin hydrochloride - korvatipat, liuos, kerta-annospakkaus - 3 mg/ml + 0,25 mg/ml - fluosinoloniasetonidi ja mikrobilääkkeet
tizanidin teva 2 mg tabletti
teva sweden ab - tizanidini hydrochloridum - tabletti - 2 mg - titsanidiini
tizanidin teva 4 mg tabletti
teva sweden ab - tizanidini hydrochloridum - tabletti - 4 mg - titsanidiini
ciproxin-hydrocortison 2 mg/ml + 10 mg/ml korvatipat, suspensio
novartis finland oy - ciprofloxacin hydrochloride, hydrocortisone - korvatipat, suspensio - 2 mg/ml + 10 mg/ml - hydrokortisoni ja mikrobilääkkeet
ducressa 1 mg/ml + 5 mg/ml silmätipat, liuos
santen oy - levofloxacin hemihydrate, dexamethasone sodium phosphate - silmätipat, liuos - 1 mg/ml + 5 mg/ml - deksametasoni ja mikrobilääkkeet
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immunoseerumit ja immunoglobuliinit, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressantit - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.